View more on these topics

Fund firms press pharms to boost developing world

A coalition of major fund management groups is warning pharmaceutical

companies that unless they boost access to urgently needed medicines

in developing nations they will face a damaging backlash.

The fund firms, which include Isis, Schroders and Jupiter, have

written to 20 leading pharmaceutical firms urging them to be more

proactive in their efforts to combat Aids and other diseases in

poorer countries such as in sub-Saharan Africa.

They are particularly concerned that the sector is blocking moves to

allow developing countries to bypass patents and want companies to

introduce differential pri-cing, which would link prices of expensive

drugs to what each country can afford.

The fund firms fear the public will lose confidence in pharmaceutical

firms, resulting in a long-term decline in their share values. Isis

says it expects to receive feedback from the companies within a year.

Isis senior analyst Olivia Lankester says: “We think the main

responsibility should be with governments but firms have got to take

action. Ongoing criticism will damage share value, long-term holdings

and firms&#39ability to protect patents.”


What&#39s for lunch?

The Budget has been delayed again this year. Concern over the effectsof war in Iraq and growing gloom over economic recession mean theChancellor needs all the time he can to get his house in order.This Budget is unusual for a number of reasons. It is rare to have anApril Budget and it will be the […]

Allianz Dresdner Asset Management – Allianz Dresdner High Income Bond Fund

Thursday, 27 March 2003 Type: Oeic Aim: Income and growth by investing in investment grade and non-investment grade bonds Minimum investment: Lump sum £500, Isa £1,000, monthly £50, Isa £200 Investment split: Up to 50% in investment grade bonds, up to 50% in non-investment grade bonds Yield: 5% gross a year Isa link: Yes Pep […]

Manor Park – Guaranteed UK Capital Growth Fund

Wednesday, 26 March 2003 Type: Guaranteed growth bond Aim: Growth linked to the performance of the FTSE 100 index Minimum-maximum investment: £5,000-no maximum Term: Five years Guarantee: Choice of 85%, 90%, 95%, 100%, 105% or 110% of capital returned in full regardless of the performance of the index Return: 185%, 155%, 125%, 95%, 65% or […]

FSA wording turns away insurers from return to market

The required wording of the FSA&#39s compliant professional indemnityinsurance policy is the biggest disincentive to encouraging insurersto come back into the market, according to PI broker Collegiate.Speaking at an FSA-hos-ted PI workshop for IFAs in London this week,Collegiate managing director Tony Howe said the wording of policieswhich compels IFAs to alert insurers over any cases […]

European Opportunities: 'It’s nice when stock selection results in a macro tailwind'

Amid significant macro headwinds in August, Mark Page explains why his fund’s focus on stock selection has helped it outperform a falling market in August. BESbswyBESbswyBESbswyBESbswyBESbswyBESbswyBESbswyBESbswyBESbswyBESbswyBESbswyBESbswy


News and expert analysis straight to your inbox

Sign up


    Leave a comment


    Why register with Money Marketing ?

    Providing trusted insight for professional advisers.  Since 1985 Money Marketing has helped promote and analyse the financial adviser community in the UK and continues to be the trusted industry brand for independent insight and advice.

    News & analysis delivered directly to your inbox
    Register today to receive our range of news alerts including daily and weekly briefings

    Money Marketing Events
    Be the first to hear about our industry leading conferences, awards, roundtables and more.

    Research and insight
    Take part in and see the results of Money Marketing's flagship investigations into industry trends.

    Have your say
    Only registered users can post comments. As the voice of the adviser community, our content generates robust debate. Sign up today and make your voice heard.

    Register now

    Having problems?

    Contact us on +44 (0)20 7292 3712

    Lines are open Monday to Friday 9:00am -5.00pm